Large-scale single-cell transcriptomics of osteosarcoma reveals extensive and different heterogeneity in primary tumors versus murine xenograft model
MetadataShow full item record
Heterogeneity within tumors has long been studied as a potential confounding factor for effective therapies, with recent studies pointing to heterogeneity resulting in distinct clonal subtypes, each with varying degrees of fitness and metastatic potential. Studies of heterogeneity have previously been limited to microscopy observations, immunohistochemistry, and flow cytometry. Recently, however, it has become possible to examine heterogeneity at a previously unexplored level: the transcriptome of individual cells. Osteosarcomas have been known to be highly heterogeneous, so we have selected osteosarcoma as our primary tumor to study as a proof-of-concept. Additionally, we have elected to create a murine patient derived xenograft (PDX) model from a primary osteosarcoma tumor and examine differences between the primary tumor and resulting xenograft at the single-cell level. Through this, we hope to better understand tumor heterogeneity and add to the current discussion in the scientific community regarding the relevance of PDX models for testing promising new therapies and personalized medicine. Through our examination of single-cell heterogeneity in osteosarcomas, we have confirmed the extensive heterogeneity previously reported, but this time at the level of mRNA. The osteosarcomas were so hetereogeneous that our resulting dataset of over 1,000 cells still did not have enough resolution to generate highly differentiated and separate groupings of cells. Upon examining inter-tumor heterogeneity, we observed the cells from different tumors to generally cluster separately. However, there were certain populations of cells from all tumors that clustered together. We also generated a PDX model and sequenced the resulting tumor, observing markedly reduced heterogeneity as compared to the original primary tumor. Importantly, the cells from the PDX model clustered within the larger group of cells from the original tumor, lending credence to the theory of clonal selection. This work presents evidence of extensive intra- and inter-tumor heterogeneity at the mRNA level within osteosarcoma tumors. This heterogeneity requires further single cell sampling to shed light on the biology of tumor diversity. Further, this heterogeneity is significantly reduced in a generated murine PDX model. This difference should serve as a potential warning about additional factors to take into account when evaluating therapies in PDX models, and suggests that further studies examining cause and effect of this observed heterogeneity are warranted.
RightsAttribution-NonCommercial-ShareAlike 4.0 International